| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |